Further, we have determined that glucocorticoid exposure during this window of development results in dysregulation of insulin and IGF1 signaling and an adaptive immune response in the TE, suggesting the potential development of altered placental capacity and metabolic disease later in life. This evidence concerns the gene IGF1 and Other metabolic disease.